Dr. Richard Stutzman, MD
Claim this profileOregon Health & Science University
Studies Reversible Corneal Opacities
Studies Fuchs' Dystrophy
8 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Richard Stutzman, MD is currently running
Optical Coherence Tomography
for Fuchs' Dystrophy
This is an observational study using optical coherence tomography (OCT) technology to quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from resolving corneal edema after surgical treatments.
Recruiting1 award N/A2 criteria
OCT Technology
for Keratoconus
The purpose of this study is to see if OCT technology can optimize scleral contact lens fittings. Subjects with keratoconus, post-penetrating keratoplasty (PK), post-LASIK ectasia, post-radial keratotomy (RK), or a variety of anterior surface disorders requiring scleral lens fittings will be considered for enrollment. For each study eye, a clinically-selected scleral lens fit will be compared against an OCT-selected lens fit. The quality of each lens fit will be determined by flourescein exam at the slit lamp. Apical clearance, limbal clearance, conjunctival compression, and lens edge lift will be assessed. A lens that satisfies all four criteria will be considered satisfactory.
Recruiting1 award N/A1 criteria
More about Richard Stutzman, MD
Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Richard Stutzman, MD has experience with
- Observational Study
- Optical Coherence Tomography
- OCT-guided Laser Phototherapeutic Keratectomy
- Optical Coherence Tomography (OCT)
- OCT-based System To Classify And Evaluate Corneal-shape Irregularities
- OCT Metrics For More Sensitive Detection Of Keratoconus Progression
Breakdown of trials Richard Stutzman, MD has run
Reversible Corneal Opacities
Fuchs' Dystrophy
Bietti Crystalline Dystrophy
Corneal Opacity
Fuchs Endothelial Corneal Dystrophy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard Stutzman, MD specialize in?
Richard Stutzman, MD focuses on Reversible Corneal Opacities and Fuchs' Dystrophy. In particular, much of their work with Reversible Corneal Opacities has involved treating patients, or patients who are undergoing treatment.
Is Richard Stutzman, MD currently recruiting for clinical trials?
Yes, Richard Stutzman, MD is currently recruiting for 8 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Richard Stutzman, MD has studied deeply?
Yes, Richard Stutzman, MD has studied treatments such as Observational Study, Optical Coherence Tomography, OCT-guided laser phototherapeutic keratectomy.
What is the best way to schedule an appointment with Richard Stutzman, MD?
Apply for one of the trials that Richard Stutzman, MD is conducting.
What is the office address of Richard Stutzman, MD?
The office of Richard Stutzman, MD is located at: Oregon Health & Science University, Portland, Oregon 97239 United States. This is the address for their practice at the Oregon Health & Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.